Invention Grant
US09119784B2 Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
有权
用粘蛋白糖蛋白（MUC-1）疫苗治疗患者的方法
- Patent Title: Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
- Patent Title (中): 用粘蛋白糖蛋白（MUC-1）疫苗治疗患者的方法
-
Application No.: US14489304Application Date: 2014-09-17
-
Publication No.: US09119784B2Publication Date: 2015-09-01
- Inventor: B. Michael Longenecker
- Applicant: Oncothyreon Inc.
- Applicant Address: US WA Seattle
- Assignee: ONCOTHYREON INC.
- Current Assignee: ONCOTHYREON INC.
- Current Assignee Address: US WA Seattle
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K9/127
- IPC: A61K9/127 ; A61K31/675 ; A61K31/739 ; A61K38/17 ; A61K38/20 ; A61K39/00 ; C12Q1/68 ; A61K47/26
Abstract:
The present invention provides a method for treating an individual who is afflicted with a cancer, such as non-small cell lung cancer or prostate cancer, by administering to that individual a MUC-1-based formulation. The formulation may be a MUC-1 based liposomal vaccine formulation.
Public/Granted literature
- US20150071990A1 Method of Treating Patients with a Mucinous Glycoprotein (MUC-1) Vaccine Public/Granted day:2015-03-12
Information query
